Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Illumina
Marketing
Illumina recruits Pfizer alum as new commercial chief
With the process of undoing its acquisition of Grail underway, Illumina is making plans for its future without the blood test maker.
Andrea Park
Jun 3, 2024 1:37pm
'The Top Line': Digital phenotyping, plus this week's headlines
Jul 14, 2023 6:00am
'The Top Line': 2023's exclusivity losses, this week's news
Apr 7, 2023 7:30am
'The Top Line': Fierce Medtech's annual Fierce 15 honorees
Mar 24, 2023 6:00am
'The Top Line': Sarepta's DMD trial, Illumina's Grail quest
Sep 9, 2022 6:00am
'The Top Line': M&A lull, highest paid R&D execs and more
May 13, 2022 6:13am
